Haleon
Rating
Updated: Sep 7, 2026Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of var...
Latest News
6 days ago · reuters.com
Advil-maker Haleon boosts US sales by targeting consumers on weight-loss drugsConsumer health company Haleon has achieved growing sales of products to counter side-effects of weight-loss drugs in the United States, the company said, capitalising on the rising popularity of GLP-1 medication.
19 days ago · reuters.com
Haleon secures better shelf space at Walmart, Target in bid to boost market shareSensodyne toothpaste maker Haleon has quietly negotiated better spots on shelves at U.S. retailers including Walmart and Target , to gain more visibility at a at a time when mounting grocery bills are hitting shopper spending.
29 days ago · proactiveinvestors.co.uk
Jefferies raises Haleon price target to 410p on margin strengthJefferies has raised its price target for Haleon (Haleon PLC (LSE:HLN, NYSE:HLN), the consumer health company behind Sensodyne and Advil, to 410p from 400p, maintaining its Buy rating. The broker highlighted a 70 basis point margin beat in the first half of the year, though it warned this revived concerns about whether Haleon was investing enough behind growth.
1 month ago · prnewswire.com
Haleon plc: Announces Pricing Terms, Expiration and Results of its Cash Tender Offer for outstanding 2027 NotesLONDON, Aug. 19, 2026 /PRNewswire/ -- Haleon plc (the "Company" or "Haleon") (LSE/NYSE: HLN) today announces the pricing terms, expiration and results of the offer to buy back any and all of the outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027 (the "Notes") of Haleon US Capital LLC's (the "Offeror"), the Company's wholly owned subsidiary (the "Tender Offer"). The Tender Offer has been made upon the terms and subject to the conditions set forth in the Offer to Purchase dated 11 August 2026 (the "Offer to Purchase").
1 month ago · prnewswire.com
Haleon plc: Cash tender offer for outstanding 2027 3.375% Fixed Rate NotesLONDON, Aug. 11, 2026 /PRNewswire/ -- Haleon plc (the "Company" or "Haleon") (LSE/NYSE: HLN) today announces that its wholly owned subsidiary, Haleon US Capital LLC (the "Offeror") is offering to buy back any and all of its outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027. Bondholders will receive a price equal to the Total Consideration based on the Reference Yield and the Fixed Spread plus Accrued Interest (each as defined below) (the "Tender Offer").
2 months ago · seekingalpha.com
Haleon plc (HLN) Q2 2026 Earnings Call Prepared Remarks TranscriptHaleon plc (HLN) Q2 2026 Earnings Call Prepared Remarks Transcript
2 months ago · seekingalpha.com
Haleon plc (HLN) Q2 2026 Earnings Call TranscriptHaleon plc (HLN) Q2 2026 Earnings Call Transcript
3 months ago · benzinga.com
Haleon Bets on Microsoft AI To Support Growth and Reach One Billion More Consumers by 2030Haleon plc (NYSE:HLN) has entered into a new five-year collaboration with Microsoft Corp. (NASDAQ:MSFT) to expand its digital, data, and artificial intelligence capabilities as the consumer health company looks to accelerate its global “Win as One” strategy.
3 months ago · businesswire.com
Haleon to Accelerate AI-powered Transformation With New Five-year Microsoft CollaborationLONDON--(BUSINESS WIRE)-- #AI--Haleon, a consumer health company solely focused on better everyday health, today announces a new five-year collaboration with Microsoft to scale digital, data and AI capabilities across the business and accelerate delivery of its global Win as One strategy. The new agreement builds on Haleon's existing use of Microsoft 365 Copilot and further supports the wider adoption of AI-powered tools across the business, helping teams automate routine tasks, collaborate more effe.
4 months ago · businesswire.com
Haleon Issues Voluntary Nationwide Recall of Gas-X Extra Strength Softgels 125mg, 120 ct. and 72 ct.WARREN, N.J.--(BUSINESS WIRE)--Haleon (NYSE: HLN) is voluntarily recalling four lots of Gas-X Extra Strength Softgels 125mg, 120 ct. and 72 ct. distributed on or about April 13, 2026 to the consumer level. The lots are being recalled due to potential contamination with a diluted propylene glycol-based coolant from a machine leakage during the packaging process. There is a potential that ingestion of the Softgels contaminated with the diluted propylene glycol-based coolant may result in adverse.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove HLN